Opinion and Comment CASE STUDY:孤立するミリアド社 2014年7月1日 Nature Biotechnology 32, 7 doi: 10.1038/nbt.2944 Myriad took no prisoners on its way to the top of the molecular diagnostics field. That strategy is unlikely to endure. Full text PDF 目次へ戻る